Table 1

Clinical characteristics of patients with primary sphenoidal non-Hodgkin lymphoma previously described in the literature

Age (yrs)/sex
Clinical symptoms and signs
Local extension
Pathology
Treatment
Reference

52/M
Reduced visual acuity, diplopia, retroorbital pain Orbital apex syndrome with blindness
Left optic canal
Diffuse large B cell type
Radiotherapy Chemotherapy
Ueba et al [15]
39/M
Nasal congestion, facial pain, paresthesia
Sellar turcica
Diffuse large T cell type
Radiotherapy CHOP-M
Weber and Loewenheim [16]
44/M
Diplopia, bilateral abducens nerve palsy
Clivus, cavernous sinus, ethmoid sinus
Diffuse large B cell type
CHOP-M
Deleu et al [3]
78/M
Diplopia, abducens nerve palsy
Clivus, cavernous sinus
Diffuse large B cell type
Radiotherapy (45 Gy)
Ferrario et al [4]
5/M
Sudden visual loss, optic neuropathy
Suprasellar cavernous sinus
Diffuse large B cell type
Radiotherapy (60 Gy) Chemotherapy*
Roth and Siatkowski [12]
64/M
Headache, diplopia, oculomotor nerve palsy
Sellar turcica, cavernous sinus
Diffuse large B cell type
COPPA-M Radiotherapy (50 Gy)
Metellus et al [8]
53/F
Headache, ptosis, oculomotor nerve palsy
Cavernous sinus
Diffuse large B cell type
CHOP-R
Present case

* CHOP-M = cyclophosphamide, adriamycin, vincristine, prednisone, and methotrexate; CHOP-R = cyclophosphamide, adriamycin, vincristine, prednisone, and rituximab; COPPA-M = cyclophosphamide, Oncovin, procarbazine, prednisone, adriamycin, and methotrexate.

Park et al. World Journal of Surgical Oncology 2007 5:86   doi:10.1186/1477-7819-5-86